Gilead COVID Patent Infringement Dispute with Chinese Research Org (2025)
October 17, 2025 | Beijing, China — MedLegalNews.com — A leading Chinese research organization has accused Gilead Sciences Inc. of infringing on a COVID-19 treatment patent, igniting a high-stakes international dispute over intellectual property and pharmaceutical innovation. The allegations center on compounds related to antiviral formulations used during the global pandemic response. Chinese Institute Claims […]
Gilead COVID Patent Infringement Dispute with Chinese Research Org (2025) Read Post »